Insulin Resistance Clinical Trials in New York, New York

4 studies are recruiting for insulin resistance in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Graded Insulin Suppression Test P&F

    The goal of this study is to learn about how the hormone insulin controls blood sugar in a variety of people. The main question it aims to answer is about how much insulin the body actually needs to maintain a normal blood sugar level. Participants will be asked to come in for a one-day study visit…

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    Columbia University Irving Medical Center, New York, New York
    Run by
    Columbia University

    See if you can join NCT06592261 on ClinicalTrials.gov

  2. Alpelisib Challenge Test (ACT)

    The goal of this study is to test a potentially easier method for measuring how much insulin a person is capable of producing than the current gold-standard method, the "hyperglycemic clamp." Participants will come in for a two-day (overnight) visit in which they will first undergo a "hyperglycemic…

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    Columbia University Irving Medical Center, New York, New York
    Run by
    Columbia University

    See if you can join NCT07778524 on ClinicalTrials.gov

  3. Human Models of Selective Insulin Resistance: Alpelisib, Part I

    The goal of this clinical trial is to understand how the blood sugar-lowering hormone insulin works in healthy adults versus those who are at risk for type 2 diabetes. The study will use a drug called alpelisib, which interferes with insulin's actions in the body, to answer the study's main questio…

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    Columbia University Irving Medical Center, New York, New York
    Run by
    Columbia University

    See if you can join NCT06354088 on ClinicalTrials.gov

  4. Effect of Insulin Lowering on Lipogenesis

    The goal of this clinical trial is to compare a one-week course of diazoxide (2 mg/kg per dose x 14 doses) and placebo in people with obesity and insulin resistance (IR) with metabolic dysfunction-associated steatotic liver disease (MASLD). The main question it aims to answer are how mitigation of …

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    Columbia University Irving Medical Center, New York, New York
    Run by
    Columbia University

    See if you can join NCT07403604 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.